besides, if you did even the little'est bit of DD, like reading a post right on this board, right in front of your face, you would have your answer. LOLOLOLOLOLOLOLO
and, that is a big part of the reason my bosses are laughing so hard at you!!!!!!
open your friggin eyes and do some simple (basic, easy) dd
BTW no one sold a share...why? That's how they could finance this well into the future. I would sell if I was getting a penny dividend a year..... I would have a very nice income.
It would cost them $270,000 of the 7 million if they owned it.. Heck if they did own double the OS do it monthly. No one would ever sell a share.
Sentiment: Strong Buy
There appears to be a question about whether Afrezza sales reported by Sanofi reflect inventories as well as actual scripts. Here is an example of how Jazz Pharmaceuticals treated revenue recognition for Xyrem and Luvox sold through distributors in a 10Q filing May 2009. Based on quotes from the 10Q, the revenue recognized does not seem to support the notion that sales include those in inventory at distributors, and assuming these same rules apply to Afrezza , there may be a good chance that the Afrezza numbers do not include inventories. A call to Matt might also clarify this for us.
Xyrem:"Revenues from sales of Xyrem within the United States are recognized upon transfer of title, which occurs when our specialty pharmaceutical distributor, Express Scripts Specialty Distribution Services, Inc., or Express Scripts, removes product from our consigned inventory location at our facility for shipment to a patient."
Luvox: "Luvox CR was approved by the U.S. Food and Drug Administration, or FDA, for the treatment of obsessive compulsive disorder and social anxiety disorder and we shipped initial stocking orders to our wholesaler customers in the first quarter of 2008. Luvox CR is subject to rights of return six months prior to and up to twelve months after product expiration. We are not able to reliably estimate expected returns of Luvox CR at the time of shipment and therefore we have recognized revenue when units were dispensed through prescriptions at which point, we believe, the product is not subject to return. In order to estimate units dispensed, we purchase dispensing data which we believe to be accurate and reliable and not subject to material adjustments from an independent prescription tracking service." (Note that they don't use independent tracking service numbers - presumably Symphony and IMS)."
This is just an example - please do your own due diligence. I can't draw definitive conclusions from this, although I am encouraged.
This is important because if it was in the front of the van, it could have been hard breaking. But being in the back IF TRUE- then we are left with one of two conclusions
1) police vans can accelerate like race cars thus throwing him backward
2) he intentionally throw himself in order to fake police brutality
TWO WEEKS of PRACTICE PULLS under her belt and STILL NOTHING
What a lot of hooey! The choice of heap leaching gave TRX a last minute reprieve to achieve commercial production in a reasonable time frame for its long suffering shareholders. Other than a few bottle roll and column tests there was a minimum amount of testing to confirm recoveries with different ore types and particle sizes. There was certainly no site-based bulk tonnage pilot test which is standard practice in the industry. Do you think there's no risk scaling up production from column testing to an actual heap leach pad? You will soon find out! Estimating costs in advance of commercial production is where the real science comes in - not after when it's too late! (I will refer you back to this comment before year end when the company's gone broke).
If I hold option, I would prefer a buyout. I am a long term holder, I would prefer not. With "$7 not a far distance", I think the stock will go over $160 in 2016. The only thing that I don't like the buyout is that it is not easy to find another good one like Sky. (may be with the help of all experts in this message boards, I can find another good one as Sky).
So, you don't care if people break the law? In this case it was both a cop and a supplier to cops that broke the law and you think that is fine?
That alone says volumes about the trash that support TASR.
Sentiment: Strong Sell
also keep in mind that berko is trading the common.
the filings prove that he's buying low and selling high. That is a documented fact that cannot be argued.
Why should I believe ANY figures you spew on this board tardshit?
But I have to admit - while I still have high hopes for EGY under Steve G. management - I'm concerned about Gabon Audit (are they using the Russian tax code in Gabon?), and the effect that low oil prices will have on Q1. (who needs all that complicated hedging) And dry hole expenses, too.
So I'll just be waiting on standby until earnings are announced, . . . . . . then cancelled & rescheduled to get more time to figure out the real numbers, . . . . . . . and then finally announced.
(i.e. no more mergers, acquisitions, for now) focus is now on DEMAND GENERATION....
And the CEO is executing it well - this statement is excellent and hits at the core of their refocus plans (away from trying to buy the next big merger company):
"The 20 percent revenue growth we achieved for the quarter is a direct result of our ongoing investments in product development, channel sales and marketing initiatives, and demand generation programs," said James Bindseil, Globalscape's President and Chief Executive Officer. "We remain confident that the plans we have in place will result in us continuing to achieve our near-term objectives that support our long-term operational and financial goals."
Very pleased with Q1 - was hoping for 20 - 30% increase in revs and that's what we got (20% revs, 33% deferred revenues - great indicator for future revs in Q3 and Q4.)
Sheff bought during the day and then he stopped out at 3.20. his blind followers panicked and all sold hence the price action yesterday, it was just a weird day for this low floater stock, looked way worse than it should've. without Sheff and that foolishness it probably would've closed at 3.20
glmcom lost all credibility when he claimed milestone payments would be amortized. Only a newbie could make that mistake.